| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 5 | +20.00% | +0.71% | -0.31% | +1.01% | +0.06% | — |
| 14d | 5 | +60.00% | -0.91% | -0.77% | -0.14% | -4.04% | — |
| 30d | 5 | +80.00% | -7.74% | -1.24% | -6.51% | -10.13% | — |
| 60d | 5 | +100.00% | -12.02% | +3.00% | -15.02% | -12.25% | — |
| 90d | 5 | +100.00% | -15.74% | +6.14% | -21.88% | -16.47% | — |
| 180d | 5 | +100.00% | -20.70% | +12.20% | -32.90% | -34.69% | — |
| 1y | 5 | +100.00% | -24.54% | +16.16% | -40.70% | -40.90% | — |
| 2y | 5(4 pending) | +100.00% | -39.55% | +33.84% | -73.39% | -73.39% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| GILD GILEAD SCIENCES, INC. | PURCHASEGRANT Stock grant | 2,355 | — | — | 11,245 | Mar 10, 2026 | Mar 12, 2026 ↗ | View → |
| GILD GILEAD SCIENCES, INC. | PURCHASEGRANT Stock grant | 5,455 | — | — | 5,455 | Mar 10, 2026 | Mar 12, 2026 ↗ | View → |
| GILD GILEAD SCIENCES, INC. | PURCHASEGRANT Stock grant | 8,890 | — | — | 8,890 | Sep 22, 2025 | Sep 23, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE10b5-1 10b5-1 plan | 1,786 | $59.31 | $105.9K | 14,173 | May 20, 2025 | May 20, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE GVP, Chief Accounting Officer | 996 | $59.27 | $59.0K | 15,959 | May 19, 2025 | May 20, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE10b5-1 10b5-1 plan | 1,295 | $71.52 | $92.6K | 16,955 | Mar 19, 2025 | Mar 20, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 9,230 | — | — | 9,230 | Mar 17, 2025 | Mar 18, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 5,970 | — | — | 18,252 | Mar 17, 2025 | Mar 18, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE GVP, Chief Accounting Officer | 823 | $69.44 | $57.1K | 12,282 | Mar 14, 2025 | Mar 18, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE10b5-1 10b5-1 plan | 1,344 | $68.38 | $91.9K | 13,105 | Feb 24, 2025 | Feb 25, 2025 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE10b5-1 10b5-1 plan | 714 | $90.00 | $64.3K | 14,449 | Aug 13, 2024 | Aug 15, 2024 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE GVP, Chief Accounting Officer | 993 | $76.97 | $76.4K | 15,163 | May 17, 2024 | May 20, 2024 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE10b5-1 10b5-1 plan | 2,286 | $90.00 | $205.7K | 16,156 | Apr 10, 2024 | Apr 12, 2024 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE GVP, Chief Accounting Officer | 372 | $83.87 | $31.2K | 18,442 | Mar 18, 2024 | Mar 19, 2024 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 7,050 | — | — | 7,050 | Mar 15, 2024 | Mar 19, 2024 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 4,720 | — | — | 18,814 | Mar 15, 2024 | Mar 19, 2024 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | SALE GVP, Chief Accounting Officer | 796 | $92.02 | $73.2K | 14,094 | May 16, 2023 | May 18, 2023 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 3,760 | — | — | 14,890 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 5,720 | — | — | 5,720 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 11,130 | — | — | 11,130 | May 16, 2022 | May 18, 2022 ↗ | View → |
| BMRN BIOMARIN PHARMACEUTICAL INC | PURCHASEGRANT Stock grant | 17,490 | — | — | 17,490 | May 16, 2022 | May 18, 2022 ↗ | View → |